Skip to Main Content
NIH LogoNIH National Cancer Institute

Dr. Jeffrey D. Lifson: Blibliography

Dr. Jefferey D. Lifson - Speaker Bibliography

Bibliographies

Included is a selective bibliography of works for a speaker presenting at the National Cancer Institute at Frederick (NCI-Frederick). Bibliographies are created and maintained by the Scientific Library staff searching standard bibliographic databases such as PubMed and Web of Science.

Dr. Jeffrey D. Lifson

Selective Bibliography of Dr. Jeffrey D. Lifson
AIDS and Cancer Virus Program, Leidos


Wednesday, October 30, 2024

 

  1. Pereira Ribeiro S, Strongin Z, Soudeyns H, Ten-Caten F, Ghneim K, Pacheco Sanchez G, Xavier de Medeiros G, Del Rio Estrada PM, Pelletier AN, Hoang T, Nguyen K, Harper J, Jean S, Wallace C, Balderas R, Lifson JD, Raghunathan G, Rimmer E, Pastuskova C, Wu G, Micci L, Ribeiro RM, Chan CN, Estes JD, Silvestri G, Gorman DM, Howell BJ, Hazuda DJ, Paiardini M, Sekaly RP
    Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
    Nature Immunology 25 (10):1900-1912 Oct 2024
  2. Xu X, Niu M, Lamberty BG, Emanuel K, Ramachandran S, Trease AJ, Tabassum M, Lifson JD, Fox HS
    Microglia and macrophages alterations in the CNS during acute SIV infection: A single-cell analysis in rhesus macaques
    PLoS Pathogens 20 (9):e1012168 Sep 2024
  3. Dias J, Fabozzi G, Fourati S, Chen X, Liu C, Ambrozak DR, Ransier A, Laboune F, Hu J, Shi W, March K, Maximova AA, Schmidt SD, Samsel J, Talana CA, Ernste K, Ko SH, Lucas ME, Radecki PE, Boswell KL, Nishimura Y, Todd JP, Martin MA, Petrovas C, Boritz EA, Doria-Rose NA, Douek DC, Sékaly RP, Lifson JD, Asokan M, Gama L, Mascola JR, Pegu A, Koup RA
    Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV(AD8-EO) infection
    Nature Communications 15 (1):7461 Aug 29 2024
  4. Varco-Merth B, Chaunzwa M, Duell DM, Marenco A, Goodwin W, Dannay R, Nekorchuk M, Shao D, Busman-Sahay K, Fennessey CM, Silipino L, Hull M, Bosche WJ, Fast R, Oswald K, Shoemaker R, Bochart R, MacAllister R, Labriola CS, Smedley JV, Axthelm MK, Davenport MP, Edlefsen PT, Estes JD, Keele BF, Lifson JD, Lewin SR, Picker LJ, Okoye AA
    Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence
    PLoS Pathogens 20 (8):e1012496 Aug 2024
  5. Melton A, Rowe LA, Penney T, Krzykwa C, Goff K, Scheuermann SE, Melton HJ, Williams K, Golden N, Green KM, Smith B, Russell-Lodrigue K, Dufour JP, Doyle-Meyers LA, Schiro F, Aye PP, Lifson JD, Beddingfield BJ, Blair RV, Bohm RP, Kolls JK, Rappaport J, Hoxie JA, Maness NJ
    The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection
    Viruses 16 (7):Jul 21 2024
  6. Immonen TT, Fennessey CM, Lipkey L, Newman L, Macairan A, Bosche M, Waltz N, Del Prete GQ, Lifson JD, Keele BF
    No evidence for ongoing replication on ART in SIV-infected macaques
    Nature Communications 15 (1):5093 Jun 14 2024
  7. Keele BF, Okoye AA, Fennessey CM, Varco-Merth B, Immonen TT, Kose E, Conchas A, Pinkevych M, Lipkey L, Newman L, Macairan A, Bosche M, Bosche WJ, Berkemeier B, Fast R, Hull M, Oswald K, Shoemaker R, Silipino L, Gorelick RJ, Duell D, Marenco A, Brantley W, Smedley J, Axthelm M, Davenport MP, Lifson JD, Picker LJ
    Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir
    PLoS Pathogens 20 (4):e1012135 Apr 2024
  8. Elizaldi SR, Hawes CE, Verma A, Shaan Lakshmanappa Y, Dinasarapu AR, Schlegel BT, Rajasundaram D, Li J, Durbin-Johnson BP, Ma ZM, Pal PB, Beckman D, Ott S, Raeman R, Lifson J, Morrison JH, Iyer SS
    Chronic SIV-Induced neuroinflammation disrupts CCR7+ CD4+ T cell immunosurveillance in the rhesus macaque brain
    Journal of Clinical Investigation 134 (9):Mar 12 2024

  9. Grunst MW, Gil HM, Grandea AG, 3rd, Snow BJ, Andrabi R, Nedellec R, Burton I, Clark NM, Janaka SK, Keles NK, Moriarty RV, Weiler AM, Capuano S, 3rd, Fennessey CM, Friedrich TC, O'Connor SL, O'Connor DH, Broman AT, Keele BF, Lifson JD, Hangartner L, Burton DR, Evans DT
    Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge

    PLoS Pathogens 20 (1):e1011819 Jan 2024

  10. Bimber BN, Sunshine J, McElfresh GW, Reed JS, Pathak R, Bateman KB, Hughes CM, Gilbride RM, Ford JC, Morrow D, Lifson JD, Sacha JB, Hansen SG, Picker LJ
    Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques
    Frontiers in Immunology 15 1444621 2024

Librarian